Toward a Molecular Pathologic Classification of Urothelial Carcinoma

May, 2010, Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications, Eur Urol, 57, 850, 10.1016/j.eururo.2009.03.052

Wu, 2005, Urothelial tumorigenesis: a tale of divergent pathways, Nat Rev Cancer, 5, 713, 10.1038/nrc1697

Lindgren, 2010, Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome, Cancer Res, 70, 3463, 10.1158/0008-5472.CAN-09-4213

Sjödahl, 2012, A molecular taxonomy for urothelial carcinoma, Clin Cancer Res, 18, 3377, 10.1158/1078-0432.CCR-12-0077-T

Jimenez, 2000, Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival, Am J Surg Pathol, 24, 980, 10.1097/00000478-200007000-00009

Amin, 2009, Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications, Mod Pathol, 22, S96, 10.1038/modpathol.2009.26

Nassar, 2004, Variants of urothelial carcinoma. Pathology of the Urinary Bladder, 117

Cheng, 2009, Staging and reporting of urothelial carcinoma of the urinary bladder, Mod Pathol, 22, S70, 10.1038/modpathol.2009.1

Sing, 2005, ROCR: visualizing classifier performance in R, Bioinformatics, 21, 3940, 10.1093/bioinformatics/bti623

Lauss, 2010, Robust assignment of cancer subtypes from expression data using a uni-variate gene expression average as classifier, BMC Cancer, 10, 532, 10.1186/1471-2407-10-532

Lindgren, 2012, Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma, PLoS One, 7, e38863, 10.1371/journal.pone.0038863

He, 2009, Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma, Stem Cells, 27, 1487, 10.1002/stem.92

Volkmer, 2012, Three differentiation states risk-stratify bladder cancer into distinct subtypes [published correction appears in Proc Natl Acad Sci U S A 2012, 109:3600], Proc Natl Acad Sci U S A, 109, 2078, 10.1073/pnas.1120605109

Chan, 2009, Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells, Proc Natl Acad Sci U S A, 106, 14016, 10.1073/pnas.0906549106

Bertucci, 2012, Basal breast cancer: a complex and deadly molecular subtype, Curr Mol Med, 12, 96, 10.2174/156652412798376134

Ho, 2012, Normal and neoplastic urothelial stem cells: getting to the root of the problem, Nat Rev Urol, 9, 583, 10.1038/nrurol.2012.142

Rieger-Christ, 2001, Expression of classic cadherins type I in urothelial neoplastic progression, Hum Pathol, 32, 18, 10.1053/hupa.2001.21140

Rebouissou, 2012, CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma, J Pathol, 227, 315, 10.1002/path.4017

Urist, 2002, Loss of p63 expression is associated with tumor progression in bladder cancer, Am J Pathol, 161, 1199, 10.1016/S0002-9440(10)64396-9

Sørlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, 11, 10869, 10.1073/pnas.191367098

Blows, 2010, Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies, PLoS Med, 25, e1000279, 10.1371/journal.pmed.1000279